Genesis Metabolics
Genesis Metabolics · 2801 Morris Avenue · Union, NJ 07083
5.0· 19 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- Medically supervised weight loss
- Endocrine / metabolic care
About this practice
Genesis Metabolics is a medical weight-loss practice in Union, New Jersey that offers telehealth. Its website describes a non-surgical approach that combines medicine with nutritional and behavioral changes and FDA-approved pharmaceutical products under the supervision of a dual-board-certified physician, delivered by a team of physicians, nutritionists, behavioral therapists and personal trainers through a five-step program. On Google it has a 5.0-star rating across 19 reviews dating back to 2022, with 1 in the past year; 8 reviews mention results and 7 mention the staff.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Yes |
| Cash pay accepted | Yes |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
Counts computed by RetaMaps from public Google reviews; most recent review 2025-12-19. Read the reviews themselves on the practice's Google listing.
What patients say
This practice holds a ★5.0 Google rating across 19 reviews. 100% of the 19 reviews we analyzed are 5-star. reviewers most often mention results (8), staff & front desk (7), professionalism & expertise (3), feeling listened to (3).
Most recent Google reviews
Joe T.★★★★★2025-12-19Dr. Scott DiGiacomo and his staff are second to none! They have taken such great care of me and I can not recommend Genesis Metabolics highly enough.
Frederick D.★★★★★2023-06-22I gave it 5 stars because I have high blood pressure and and worrying about the health risks involving high blood pressure.Dr. Scott felt that I was a great candidate for the program. I’ve been with the DiGiacomo’s since I was born. I’m 58 now.That’s 4 generations of great doctors. I went from 260 lbs to 195lbs with out surgery. This program has completely changed my life. What Dr. Scott is providing is a safe and effective weight lost program. Believe me, there’s a lot a scammers out there that take your money with no results. I’m proof that his method of weight lost works. This program is the real deal.
Byron. b.★★★★★2023-05-29This program is the very best in the country and has turned my life around completely. Dr.DiGiacomo has changed my life and turned my health around to its best potential. I've loss over 50 pounds on this program and I feel great plus my overall health has dramatically improved. Dr.DiGiacomo is the very best physician in the State of NJ and his staff is terrific. I recommend this program to all who suffer from obesity and health issues. Thank you so much Byron Teal.💪👍👍👍
Lourdes A.★★★★★2023-05-17Had an amazing experience in my weight loss journey. I lost 42 pounds in 7 months without stress and learned how to eat healthier along the way.. I would recommend swing Dr. Scott 100%.
Stefanie M.★★★★★2023-04-26Highly recommended. I started my process in June 2022 and its now 5 months later & I have lost a drastic amount of weight. This is definitely trustworthy as I was hesitant in the beginning. I feel so much better & look different. The staff is amazing as well. thanks for everything.
Reviews and counts are from this practice's public Google Business listing and reflect their authors' opinions, not RetaMaps'. See all reviews on Google.
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs